A9542 HCPCS code: Indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries

A9542 is the HCPCS Level II code for indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1 per day on outpatient hospital claims.

Code details

FieldValue
SectionA codes — Transportation, medical/surgical supplies and miscellaneous
Coverage codeC — Carrier judgment
Pricing indicator51 — Drug or biological (priced per ASP/average sales price rules)
BETOS categoryI1E
Added2006-01-01
Last action effective2025-01-01

NCCI unit limits (MUE)

Claim typeMax units per dayRationale
outpatient hospital claims1Code Descriptor / CPT Instruction
practitioner claims1Code Descriptor / CPT Instruction

What changed for A9542

Frequently asked questions

What is HCPCS code A9542?

A9542 is the HCPCS Level II code for indium in-111 ibritumomab tiuxetan, diagnostic, per study dose, up to 5 millicuries. Short descriptor: "In111 ibritumomab, dx".

Does Medicare cover A9542?

Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.

How many units of A9542 can be billed per day?

1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).

Related A95 codes

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.

All A codes · HCPCS lookup